|
1
|
http://ganjoho.jp/reg_stat/statistics/brochure/backnumber/2014_jp.htmlCancer
statistics in Japan-2014. March 14–2016
|
|
2
|
National Comprehensive Cancer Network, .
NCCN clinical practice guidelines in oncology: Head and neck
cancers. Version 1. 2012.http://www.nccn.org/clinical.aspMarch
14–2016
|
|
3
|
Inagi K, Takahashi H, Okamoto MA, Nakayama
M, Makoshi T and Nagai H: Treatment effects in patients with
squamous cell carcinoma of the oral cavity. Acta Oto-Laryngol.
122:25–29. 2002. View Article : Google Scholar
|
|
4
|
Penning TM and Drury JE: Human aldo-keto
reductases: Function, gene regulation, and single nucleotide
polymorphisms. Arch Biochem Biophys. 464:241–250. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mindnich RD and Pennning TM: Aldo-Keto
Reductase (Akr) superfamily: Genomics and annotation. Hum Genomics.
3:362–370. 2009.PubMed/NCBI
|
|
6
|
Miura T, Nishinaka T and Terada T:
Different functions between human monomeric carbonyl reductase 3
and carbonyl reductase 1. Mol Cell Biochem. 315:113–121. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gonzales-Covarrubias V, Ghosh D, Lakhman
SS, Pendyala L and Blanco JG: A functional genetic polymorphism on
human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic
activity and NADPH binding affinity. Drug Metab Dispos. 35:973–980.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ismail E, Al-Mulla F, Tsuchida S, Suto K,
Motley P, Harrison PR and Birnie GD: Carbonyl reductase: A novel
metastasis-modulating function. Cancer Res. 60:1173–1176.
2000.PubMed/NCBI
|
|
9
|
Murakami A, Fukushima C, Yoshidomi K,
Sueoka K, Nawata S, Yokoyama Y, Tsuchida S, Ismail E, Al-Mulla F
and Sugino N: Suppression of carbonyl reductase expression enhances
malignant behaviour in uterine cervical squamous cell carcinoma:
Carbonyl reductase predicts prognosis and lymph node metastasis.
Cancer Lett. 311:77–84. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Umemoto M, Yokoyama Y, Sato S, Tsuchida S,
Al-Mulla F and Saito Y: Carbonyl reductase as a significant
predictor of survival and lymph node metastasis in epithelial
ovarian cancer. Brit J Cancer. 85:1032–1036. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Leslie SH and Christian W: TNM
Classification of Malignant Tumours. 6th. International union
against cancer (UICC). Wiley-Blackwell; pp. 2642002
|
|
12
|
Pindborg JJ, Reichart PA, Smith CJ and van
der Waal I: Histological typing of cancer and precancer of the oral
mucosa. 2nd. World health organization (WHO). Springer-verlag; pp.
871997
|
|
13
|
Murakami A, Yakabe K, Yoshidomi K, Sueoka
K, Nawata S, Yokoyama Y, Tsuchida S, Al-Mulla F and Sugino N:
Decreased carbonyl reductase 1 expression promotes malignant
behaviours by induction of epithelial mesenchymal transition and
its clinical significance. Cancer Lett. 323:69–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harada K, Ferdous T and Ueyama Y:
Establishment of 5-fluorouracil-resistant oral squamous cell
carcinoma cell lines with epithelial to mesenchymal transition
changes. Int J Oncol. 44:1302–1308. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Osawa Y, Yokoyama Y, Shigeto T, Futagami M
and Mizunuma H: Decreased expression of carbonyl reductase 1
promotes ovarian cancer growth and proliferation. Int J Oncol.
46:1252–1258. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cervical Cancer Treatment (PDQ®)-Health
Professional Version, . National Cancer Institute. https://www.cancer.gov/types/cervical/hp/cervical-treatment-pdq#section/August
31–2016
|
|
17
|
Miura R, Yokoyama Y, Shigeto T, Futagami M
and Mizunuma H: Inhibitory effect of carbonyl reductase 1 on
ovarian cancer growth via tumor necrosis factor receptor signaling.
Int J Oncol. 47:2173–2180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schipper JH, Frixen UH, Behrens J, Unger
A, Jahnke K and Birchmeier W: E-cadherin expression in squamous
cell carcinomas of head and neck: Inverse correlation with tumor
dedifferentiation and lymph node metastasis. Cancer Res.
51:6328–6337. 1991.PubMed/NCBI
|
|
19
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Momose F, Araida T, Negishi A, Ichijo H,
Shioda S and Sasaki S: Variant sublines with different metastatic
potentials selected in nude mice from human oral squamous cell
carcinomas. J Oral Pathol Med. 18:391–395. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Takahashi H, Shigeta T, Umeda M and Komori
T: A new in vitro invasion model for oral cancer using an acellular
allogenic dermal matrix (Alloderm): The relationship among in vitro
invasion activity, in vivo invasion and metastasis. Kobe J Med Sci.
57:E128–E136. 2012.PubMed/NCBI
|
